Breaking News in Medical Devices

You may have heard about Boston Scientific’s latest achievement in medical device technology. The company confirmed that their new coronary ultrasound imaging diagnostic device, the “AVVIGO+ Multi-Modality Guidance System” has received regulatory approval from South Korea’s Ministry of Food and Drug Safety.

AVVIGO+ Multi-Modality Guidance System

Key Features:

Automated Lesion Assessment (ALA): This feature brings automation to lesion evaluation and vascular measurement.
Flexible Imaging Catheter Options: Enhances procedure efficiency by supporting various pull-back speeds.
Real-time Graphs for FFR and DFR: Displays changes over time during procedures to aid decision-making.

According to the European Society of Cardiology’s updated guidelines, using Intravascular Ultrasound (IVUS) now has the highest recommendation for complex interventions, highlighting a significant reduction in complications compared to angiography-guided procedures.

Intuitive’s Da Vinci 5 Surgical System

Intuitive is rolling out its next-gen robot-assisted surgical system, “Da Vinci 5”, in Korea. This system aims to enhance surgical outcomes and surgeon autonomy.

Improvements Include:

Force Feedback Technology: Helps reduce trauma and improve precision.
Ergonomic Design: Enhances work environment with curved armrests and immersive consoles.
Advanced Vision System: Offers high-resolution 3D imaging for better anatomical visualization.

Da Vinci 5 aims to reduce surgery time and promote quicker patient recovery. It integrates with a digital platform for a comprehensive technological experience.

Humedix’s Ella Vie Mela Return Cushion

Humedix’s Ella Vie Mela Return Cushion, featured once more on home shopping channels, does more than cover skin imperfections.

Product Highlights:

62% Skincare Ingredient Content: Provides moisturizing effects lasting up to 150 hours.
SPF 50, PA++++: Protects against UV, while promoting healthy skin.

The cushion offers pore coverage, anti-darkening properties, and a seamless makeup adherence, making it a skincare and cosmetic hybrid.

Wontech’s Expansion Into the Chinese Market

Marking its 25th anniversary, Wontech is aiming to strengthen its foothold in the Chinese market by hosting seminars in Shanghai and showcasing products at the AMWC CHINA 2024 conference.

Key Products:

Lavieen and Picocare450: Received positive feedback from local medical professionals.
Picocare Majesty: Expected to receive China’s NMPA approval, indicating market entry potential.

Wontech’s engagement at these events aims to bolster its market share within China through strategic collaborations.

3BIGS Secures $2M Investment

Bio big data platform specialist 3BIGS is expanding its footprint in Southeast Asia with the help of a $2 million investment from British firm ASC Prime Capital Holdings Ltd.

Expansion Strategies:

Joint Venture in the Philippines: Establishes 3BIGS INTERNATIONAL to introduce advanced health diagnostics.
Middle East Expansion: Plans to set up operations in Dubai and expand the Indian market presence.

3BIGS aims to leverage this funding for broadening its activities in global health markets.

Curacle and Maptics at BIO-Europe 2024

Curacle, a company specializing in refractory vascular diseases, alongside its partner Maptics, will present at BIO-Europe 2024.

Research focuses:

MT-101: Targets acute kidney injury and chronic kidney disease with significant preliminary results.
MT-103: Works on both VEGF and Ang-2 pathways for treating retinal vascular diseases.

These initiatives reflect Curacle’s commitment to innovating solutions for challenging vascular conditions.

Stay updated with the latest advancements in medical technologies to understand how these developments impact healthcare systems globally.